Can a pharmacist help people with HIV avoid falls and brain fog? new study aims to find out.

NCT ID NCT06513819

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests a program where a clinical pharmacist talks with people with HIV about the risks of drinking alcohol (with or without cannabis) while taking multiple medications, especially those that affect the brain. The goal is to see if this approach can reduce falls and improve thinking. The study will enroll 100 participants from VA sites and measure how well the program works and how acceptable it is to participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Information Motivation Behavioral and Motivational Interviewing (IMB-MI) technique
What this could lead to
If successful, this could lead to a practical program that helps people with HIV reduce their risk of falls and thinking problems by managing alcohol, cannabis, and medication use.
What could go wrong
This is a very early pilot study with only 100 participants, focused on whether the program is feasible and acceptable, not on proving it works. Results may not apply to all people with HIV.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL DRINKING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • VA Connecticut Healthcare System

    RECRUITING

    West Haven, Connecticut, 06516, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.